Clinical trial
Treatment of Psoriatic Arthritis With hOKT3γ1 (Ala-Ala)
NCT00239720 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Psoriatic Arthritis With hOKT3γ1 (Ala-Ala)
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 16, 2006
- Completion date
- June 25, 2008
- Enrollment
- 4 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.